Sanofi SA 1Q 2014-- Forecast

FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) first-quarter results, based on a poll of seven analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released April 29.

=== 
                  Net      Business    Business    Business 
1st Quarter     sales  Oper. Income  net income         EPS 
 
AVERAGE         8,023         2,251       1,583        1.20 
Prev. Year      8,059         2,344       1,613        1.22 
+/- in %         -0.4          -4.0        -1.9        -1.8 
 
MEDIAN          7,998         2,226       1,585        1.20 
Maximum         8,175         2,334       1,613        1.22 
Minimum         7,866         2,205       1,551        1.18 
Amount              7             7           7           7 
 
Barclays        8,113         2,334       1,613        1.22 
Bernstein       8,026         2,305       1,603        1.21 
CM-CIC Sec.     7,998         2,216       1,597        1.21 
Credit Suisse   7,998         2,205       1,551        1.18 
Deutsche Bank   7,866         2,226       1,557        1.18 
Helvea          7,985         2,252       1,574        1.19 
J.P. Morgan     8,175         2,221       1,585        1.20 
 
         Target price  Rating                      DPS 2014 
 
AVERAGE         85.25  positive 3     AVERAGE          2.83 
Prev. Quarter   83.07  neutral  2     Prev. Year       2.80 
+/- in %         +2.6  negative 0     +/- in %         +1.0 
 
MEDIAN          83.50                 MEDIAN           2.89 
Maximum         95.00                 Maximum          2.95 
Minimum         79.00                 Minimum          2.64 
Amount              4                 Amount              3 
 
Barclays        95.00  Overweight                      2.89 
Credit Suisse   80.00  Neutral                         2.64 
Deutsche Bank   87.00  Buy                             2.95 
Helvea          79.00  Buy                               -- 
J.P. Morgan        --  Neutral                           -- 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires